Indaptus Therapeutics, Inc. (INDP) vs Neurogene Inc. (NGNE)
Indaptus Therapeutics, Inc. and Neurogene Inc. are both Biotechnology companies. Indaptus Therapeutics, Inc. and Neurogene Inc. are of similar size ($625.4M and $606.8M). Across the 8 metrics below, Indaptus Therapeutics, Inc. leads on 4 and Neurogene Inc. on 4.
Valuation
Profitability
| Metric | INDP | NGNE | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (318.04%) | (45.32%) | (57.72%) |
| Return on assets | (163.84%) | (41.02%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack